Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Development of Fe3O4 core–TiO2 shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization

Fig. 2

Cryo-XFM imaging of SK-N-AS cells treated with three different nanocomposites. a SK-N-AS cells were treated with 250 nM Fe3O4@TiO2 nanocomposites for 1 h. The distribution of Ti and Fe (as proxy for nanocomposites) in SK-N-AS cells was cytoplasmic or associated with the membrane; b the same cell was imaged after a 45 degree rotation, with all Ti signal separated from the Zn-rich area of the nucleus; c SK-N-AS cells treated with DOPAC–Fe3O4@TiO2 nanoconjugates showing large aggregates with dense concentration of Ti and Fe; d SK-N-AS cells also display punctate pattern of smaller aggregates of nanocomposites apparently co-localizing with Mn and Zn signal. e SK-N-AS cells treated with MIBG–Fe3O4@TiO2 nanoconjugates. Some co-localization of Ti and Fe puncta with Mn and Zn is observed, indicating either potential mitochondrial or nuclear distribution of MIBG–Fe3O4@TiO2 nanoconjugates. f After a + 60 degree rotation, image of the lower portion of same cell is still indicating Ti and Mn co-localization for aggregates nc 3 and nc 4; g scan of the upper portion of the same cell after a -60 degree rotation suggests that aggregate nc1 is in fact immediately above the nucleus. Scale bar and elemental concentration indicator (black—no signal to red—highest signal) are located under each image

Back to article page